19.20
price down icon9.22%   -1.95
after-market 시간 외 거래: 19.01 -0.19 -0.99%
loading
전일 마감가:
$21.15
열려 있는:
$21.13
하루 거래량:
409.16K
Relative Volume:
12.03
시가총액:
$1.16B
수익:
-
순이익/손실:
$-15.84M
주가수익비율:
-1.5868
EPS:
-12.1
순현금흐름:
$-12.23M
1주 성능:
-27.19%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$17.98
$22.04
1주일 범위
Value
$17.98
$27.60
52주 변동 폭
Value
$17.98
$27.60

Damora Therapeutics Inc Stock (DMRA) Company Profile

Name
명칭
Damora Therapeutics Inc
Name
전화
45-70-70-52-10
Name
주소
75 STATE STREET, BOSTON
Name
직원
5
Name
트위터
Name
다음 수익 날짜
2026-03-18
Name
최신 SEC 제출 서류
Name
DMRA's Discussions on Twitter

Compare DMRA vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DMRA
Damora Therapeutics Inc
19.20 1.27B 0 -15.84M -12.23M -12.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.05 114.72B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
737.45 78.67B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
684.50 42.38B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
311.10 41.75B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
282.72 31.33B 5.36B 287.73M 924.18M 2.5229

Damora Therapeutics Inc Stock (DMRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-02-17 개시 UBS Buy
2026-01-07 개시 Leerink Partners Outperform
2025-12-01 개시 Guggenheim Buy
2021-04-26 재개 Credit Suisse Outperform
2020-11-23 개시 BofA Securities Buy
2020-11-23 개시 Credit Suisse Outperform
2020-11-23 개시 SVB Leerink Outperform
모두보기

Damora Therapeutics Inc 주식(DMRA)의 최신 뉴스

pulisher
04:23 AM

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Trading Down 10%What's Next? - MarketBeat

04:23 AM
pulisher
04:10 AM

Biotech Damora says $535M can carry its lead blood-disorder drug into Phase 3 - Stock Titan

04:10 AM
pulisher
03:23 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Earnings Date and Reports 2026 - MarketBeat

03:23 AM
pulisher
02:16 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Institutional Ownership 2026 - MarketBeat

02:16 AM
pulisher
01:39 AM

Damora Therapeutics, Inc. Common Stock (DMRA) 10K Form and SEC Filings 2026 - MarketBeat

01:39 AM
pulisher
01:12 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Insider Trading Activity 2026 - MarketBeat

01:12 AM
pulisher
01:09 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Trends and Sentiment 2026 - MarketBeat

01:09 AM
pulisher
01:09 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Price, News & Analysis - MarketBeat

01:09 AM
pulisher
01:08 AM

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

01:08 AM
pulisher
01:08 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat

01:08 AM
pulisher
01:06 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Forecast and Price Target 2026 - MarketBeat

01:06 AM
pulisher
01:05 AM

Damora Therapeutics, Inc. Common Stock (DMRA) Stock Chart and Price History 2026 - MarketBeat

01:05 AM
pulisher
Mar 17, 2026

Galecto rebrands as Damora Therapeutics, begins Nasdaq trading - Investing.com Nigeria

Mar 17, 2026
pulisher
Mar 17, 2026

Non-controlling/minority interest of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 17, 2026
pulisher
Mar 13, 2026

Taxes of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 13, 2026
pulisher
Mar 12, 2026

Inventory turnover of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Return on invested capital % of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Inventory turnover of Damora Therapeutics, Inc. – BOATS:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

Discontinued operations of Damora Therapeutics, Inc. – BOATS:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

After tax other income/expense of Damora Therapeutics, Inc. – BOATS:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 12, 2026

DMRA Stock Price and Chart — BOATS:DMRA - TradingView

Mar 12, 2026
pulisher
Mar 11, 2026

Price to cash flow ratio of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Total common shares outstanding of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Number of employees of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Enterprise value to EBITDA ratio of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

CapEx per share of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Working capital per share of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Financial Statements – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Free cash flow per share of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Quick ratio of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Net margin % of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Net current asset value per share of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Operating cash flow per share of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Cash from operating activities of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Cash from investing activities of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Enterprise value of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

EBITDA margin % of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Gross margin % of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Statistics – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Earnings and Revenue – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Cash Flow – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Total liabilities & shareholders' equities of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Total assets of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Net debt of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Total debt of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Revenue Breakdown – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Balance Sheet – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Dilution adjustment of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Damora Therapeutics, Inc. Dividends – NASDAQ:DMRA - TradingView

Mar 11, 2026
pulisher
Mar 11, 2026

Diluted shares outstanding of Damora Therapeutics, Inc. – NASDAQ:DMRA - TradingView

Mar 11, 2026

Damora Therapeutics Inc (DMRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):